CA
JNJ icon

Clune & Associates’s Johnson & Johnson JNJ Stock Holding History

Clune & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Sell
976
-247
-20% -$57.6K 0.04% 154
2026
Q1 		$299K Buy
+1,223
New +$285K 0.06% 140

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Clune & Associates's JNJ Position: Q2 2026 in Review

Clune & Associates reduced its Johnson & Johnson (JNJ) stake by 20% in Q2 2026, selling an estimated $57.6K and leaving 976 shares worth $248K. The position accounts for 0.04% of the portfolio, ranked #154.

Clune & Associates first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. The position peaked at $299K in Q1 2026. 1,173 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Clune & Associates held 976 shares of Johnson & Johnson worth $248K as of Q2 2026.
  • Clune & Associates sold 247 Johnson & Johnson shares in Q2 2026, an estimated $57.6K.
  • Johnson & Johnson made up 0.04% of Clune & Associates's portfolio in Q2 2026, its #154 holding.
  • Clune & Associates first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
  • Clune & Associates's Johnson & Johnson position peaked at $299K in Q1 2026.
  • 1,173 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Clune & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.